Chapman H A, Riese R J, Shi G P
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Annu Rev Physiol. 1997;59:63-88. doi: 10.1146/annurev.physiol.59.1.63.
Cysteine proteases have traditionally been viewed as lysosomal mediators of terminal protein degradation. However, recent findings refute this limited view and suggest a more expanded role for cysteine proteases in human biology. Several newly discovered members of this enzyme class are regulated proteases with limited tissue expression, which implies specific roles in cellular physiology. These roles appear to include apoptosis, MHC class II immune responses, prohormone processing, and extracellular matrix remodeling important to bone development. The ability of macrophages and other cells to mobilize elastolytic cysteine proteases to their surfaces under specialized conditions may also lead to accelerated collagen and elastin degradation at sites of inflammation in diseases such as atherosclerosis and emphysema. The development of inhibitors of specific cysteine proteases promises to provide new drugs for modifying immunity, osteoporosis, and chronic inflammation.
传统上,半胱氨酸蛋白酶被视为终末蛋白质降解的溶酶体介质。然而,最近的研究结果驳斥了这种有限的观点,并表明半胱氨酸蛋白酶在人类生物学中具有更广泛的作用。该酶家族的几个新发现成员是受调控的蛋白酶,组织表达有限,这意味着它们在细胞生理学中具有特定作用。这些作用似乎包括细胞凋亡、MHC II类免疫反应、激素原加工以及对骨骼发育至关重要的细胞外基质重塑。巨噬细胞和其他细胞在特定条件下将弹性溶解半胱氨酸蛋白酶转运到其表面的能力,也可能导致动脉粥样硬化和肺气肿等疾病炎症部位的胶原蛋白和弹性蛋白加速降解。开发特定半胱氨酸蛋白酶的抑制剂有望为调节免疫、骨质疏松症和慢性炎症提供新药。